Literature DB >> 3703267

Adynamia episodica and paralysis periodica paramyotonica.

K Ricker, R Rohkamm, R Böhlen.   

Abstract

We studied hyperkalemic attacks in one family with adynamia episodica (AE) and one family with paralysis periodica paramyotonica (PPP). Under exercise, serum potassium increased as in healthy subjects. Thiazide did not affect this increase. Thirty minutes after exercise, a second potassium increase occurred, but could be prevented by thiazide and not by mexiletine. After cooling, muscle relaxation time was normal in AE but increased up to 100 times in PPP; this cooling effect was prevented by mexiletine. Although hyperkalemic attacks are similar in AE and in PPP, the membrane defect in PPP seems more complex.

Entities:  

Mesh:

Year:  1986        PMID: 3703267     DOI: 10.1212/wnl.36.5.682

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Linkage data suggesting allelic heterogeneity for paramyotonia congenita and hyperkalemic periodic paralysis on chromosome 17.

Authors:  M C Koch; K Ricker; M Otto; T Grimm; K Bender; B Zoll; P S Harper; F Lehmann-Horn; R Rüdel; E P Hoffman
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

2.  Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica.

Authors:  J Kim; Y Hahn; E H Sohn; Y J Lee; J H Yun; J M Kim; J H Chung
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

3.  Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.

Authors:  Jean-François Desaphy; Concetta Altamura; Savine Vicart; Bertrand Fontaine
Journal:  J Neuromuscul Dis       Date:  2021

4.  Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel.

Authors:  Ann-Marie Chapman; Marieke Schurer; Laure Weijers; Amer Omar; Hiba Lee; Alla Zozulya Weidenfeller; Crispin Ellis; Shaneil Sonecha; Christiane Schneider-Gold
Journal:  BMC Neurol       Date:  2021-12-01       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.